Live and let die: regulatory mechanisms in Fas-mediated apoptosis

被引:159
作者
Curtin, JF [1 ]
Cotter, TG [1 ]
机构
[1] Natl Univ Ireland Univ Coll Cork, Biosci Res Inst, Dept Biochem, Tumour Biol Lab, Cork, Ireland
关键词
Fas; CD95; regulation; death receptors; DISC; gene expression;
D O I
10.1016/S0898-6568(03)00093-7
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Activation of Fas receptor by Fas ligand causes caspase 8 activation and apoptosis in cells and is an important mechanism by which normal tissue homeostasis and function are maintained. Activation of caspase 8 is preceded by the formation of a death-inducing signalling complex (DISC), and a number of redundant mechanisms regulate DISC formation in vivo. Fas receptor is widely expressed in tissues, and dysfunction of the regulatory mechanisms in Fas receptor signalling has been reported in several diseases including autoimmune disease and cancer. This review aims to identify and discuss the various mechanisms employed by cells to alter their sensitivity to Fas-mediated apoptosis by regulating DISC formation. We also discuss a number of defects identified with Fas receptor signalling and the associated pathologies. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:983 / 992
页数:10
相关论文
共 160 条
[91]   Distinct molecular mechanisms of Fas resistance in murine B lymphoma cells [J].
Mueller, CM ;
Scott, DW .
JOURNAL OF IMMUNOLOGY, 2000, 165 (04) :1854-1862
[92]   Antigen-dependent release of IFN-γ by cytotoxic T cells up-regulates Fas on target cells and facilitates exocytosis-independent specific target cell lysis [J].
Müllbacher, A ;
Lobigs, M ;
Hla, RT ;
Tran, T ;
Stehle, T ;
Simon, MM .
JOURNAL OF IMMUNOLOGY, 2002, 169 (01) :145-150
[93]   p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs [J].
Müller, M ;
Wilder, S ;
Bannasch, D ;
Israeli, D ;
Lehlbach, K ;
Li-Weber, M ;
Friedman, SL ;
Galle, PR ;
Stremmel, W ;
Oren, M ;
Krammer, PH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (11) :2033-2045
[94]   FADD/MORT1 regulates the pre-TCR checkpoint and can function as a tumour suppressor [J].
Newton, K ;
Harris, AW ;
Strasser, A .
EMBO JOURNAL, 2000, 19 (05) :931-941
[95]   Caspase structure, proteolytic substrates, and function during apoptotic cell death [J].
Nicholson, DW .
CELL DEATH AND DIFFERENTIATION, 1999, 6 (11) :1028-1042
[96]   SOLUBLE FORMS OF TUMOR-NECROSIS-FACTOR RECEPTORS (TNF-RS) - THE CDNA FOR THE TYPE-I TNF-R, CLONED USING AMINO-ACID-SEQUENCE DATA OF ITS SOLUBLE FORM, ENCODES BOTH THE CELL-SURFACE AND A SOLUBLE FORM OF THE RECEPTOR [J].
NOPHAR, Y ;
KEMPER, O ;
BRAKEBUSCH, C ;
ENGELMANN, H ;
ZWANG, R ;
ADERKA, D ;
HOLTMANN, H ;
WALLACH, D .
EMBO JOURNAL, 1990, 9 (10) :3269-3278
[97]  
Okura T, 1996, J IMMUNOL, V157, P4277
[98]  
Oshimi Y, 1996, J IMMUNOL, V157, P2909
[99]   An antagonist decoy receptor and a death domain-containing receptor for TRAIL [J].
Pan, GH ;
Ni, J ;
Wei, YF ;
Yu, GL ;
Gentz, R ;
Dixit, VM .
SCIENCE, 1997, 277 (5327) :815-818
[100]   Identification and functional characterization of DR6, a novel death domain-containing TNF receptor [J].
Pan, GH ;
Bauer, JH ;
Haridas, V ;
Wang, SX ;
Liu, D ;
Yu, GL ;
Vincenz, C ;
Aggarwal, BB ;
Ni, J ;
Dixit, VM .
FEBS LETTERS, 1998, 431 (03) :351-356